Takeda

News

CSL preps filings for once-monthly antibody for HAE

Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial y

News

After coeliac fail, 9 Meters plots phase 3 in short bowel sy...

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndr

News

Takeda bolsters data for dengue jab as regulatory reviews ro...

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds the case for the shot as regulators review marketing applications.

Market Access

Closing the digital expectation gap in pharma

Jan Deman is Takeda’s head of digital customer experience for Europe and Canada. But he’d prefer not to refer to what he does as “innovation”.

News

Takeda, Daiichi-backed wearable study planned in Japan

A study that will look at the feasibility of tracking people's lifestyle habits for an extended period using a wearable device has got underway in Japan, backed by drugmakers Takeda and Dai

Market Access